Cardiol Therapeutics

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
14161Y200
SEDOL
BHZT969
CIK
N/A
cardiolrx.com
LEI:
©
FIGI: BBG00M0GNP68
CRDL
Cardiol Therapeutics
GICS: - · Sector: - · Sub-Sector: -
AI
PROFILER
NAME
Cardiol Therapeutics
ISIN
CA14161Y2006
TICKER
CRDL
MIC
XTSE
REUTERS
CRDL.TO
BLOOMBERG
CRDL CN
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Fri, 22.11.2024

Original-Research: Cardiol Therapeutics Inc - from First Berlin Equity Research GmbH 22.11.2024 / 11:05 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to...
Research & Analysis
Read more
Mon, 28.10.2024

Original-Research: Cardiol Therapeutics Inc - from First Berlin Equity Research GmbH 28.10.2024 / 15:45 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to...
Research & Analysis
Read more
Fri, 14.06.2024

Original-Research: Cardiol Therapeutics Inc - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Cardiol Therapeutics Inc Company Name: Cardiol Therapeutics Inc ISIN: CA14161Y2006 Reason for the research: Update Recommendation: Buy from: 14.06.2024 Target price: USD8.50 Target price on sight of: 12 months...
Research & Analysis
Read more
Tue, 27.02.2024

Original-Research: Cardiol Therapeutics Inc - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Cardiol Therapeutics Inc Company Name: Cardiol Therapeutics Inc ISIN: CA14161Y2006 Reason for the research: Update Recommendation: Buy from: 27.02.2024 Target price: USD 3.60 Target price on sight of: 12 month...
Research & Analysis
Read more
Fri, 19.01.2024

Original-Research: Cardiol Therapeutics Inc - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Cardiol Therapeutics Inc Unternehmen: Cardiol Therapeutics Inc ISIN: CA14161Y2006 Anlass der Studie: Update Empfehlung: Buy seit: 19.01.2024 Kursziel: USD 3.60 Kursziel auf Sicht von: 12 months Letzte Ratingänderu...
Research & Analysis
Read more
Wed, 30.08.2023

Original-Research: Cardiol Therapeutics Inc - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Cardiol Therapeutics Inc Unternehmen: Cardiol Therapeutics Inc ISIN: CA14161Y2006 Anlass der Studie: Update Empfehlung: Buy seit: 30.08.2023 Kursziel: USD 3,60 / €3,30 Kursziel auf Sicht von: 12 months Letzte Rati...
Research & Analysis
Read more
Wed, 24.05.2023

Original-Research: Cardiol Therapeutics Inc - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Cardiol Therapeutics Inc Unternehmen: Cardiol Therapeutics Inc ISIN: CA14161Y2006 Anlass der Studie: Update Empfehlung: Buy seit: 24.05.2023 Kursziel: USD 3,60 (€3,30) Kursziel auf Sicht von: 12 Monate Letzte Ratin...
Research & Analysis
Read more
Wed, 24.05.2023

Original-Research: Cardiol Therapeutics Inc - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Cardiol Therapeutics Inc Unternehmen: Cardiol Therapeutics Inc ISIN: CA14161Y2006 Anlass der Studie: Update Empfehlung: Buy seit: 24.05.2023 Kursziel: USD 3,60 (€3,30) Kursziel auf Sicht von: 12 Monate Letzte Ratin...
Research & Analysis
Read more
Tue, 11.04.2023

Original-Research: Cardiol Therapeutics Inc - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Cardiol Therapeutics Inc Unternehmen: Cardiol Therapeutics Inc ISIN: CA14161Y2006 Anlass der Studie: Aufnahme der Coverage Empfehlung: Buy seit: 11.04.2023 Kursziel: USD 3,60 (€3,30) Kursziel auf Sicht von: 12 Mona...
Research & Analysis
Read more
Tue, 11.04.2023

Original-Research: Cardiol Therapeutics Inc - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Cardiol Therapeutics Inc Unternehmen: Cardiol Therapeutics Inc ISIN: CA14161Y2006 Anlass der Studie: Aufnahme der Coverage Empfehlung: Buy seit: 11.04.2023 Kursziel: USD 3,60 (€3,30) Kursziel auf Sicht von: 12 Mona...
Research & Analysis
Read more
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S